| Name | Title | Contact Details |
|---|
Transtech Medical Solutions, LLC is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Headquartered in Omaha, Nebraska, Banyan Medical Systems, Inc. is a leading-edge medical software development and integration company dedicated to creating solutions that transform healthcare professionals` ability to access and interact with patient information. Our products and services are also designed to optimize efficiency, improve workflow, help ensure patient safety, and provide the highest levels of productivity and flexibility. As a result, we are uniquely positioned to provide healthcare professionals with the vital information they need to deliver better, more personalized healthcare to patients whether it be in the OR, clinic, or through real-time collaboration. Banyan Medical Systems healthcare services include consultation, software development and installation, training, and service support, as well as innovative custom solutions. Banyan has developed a series of integrated solutions that provide advantages not offered elsewhere, including: •Integration with all platforms, regardless of vendor •Ability to leverage current equipment and software, creating a seamless system •Scalability for easy expansion or re-design •Portability, including remote access
Five Star Orthodontic Lab is a Denton, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
PlanVista Corporation is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.